Smilow Cancer Center/Yale-New Haven Hospital is a clinical research site located in New Haven, Connecticut, United States 06510.
Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.
Smilow Cancer Center/Yale-New Haven Hospital has participated in 126 clinical trials with 90 currently active.
Therapeutic areas: Refractory Differentiated Thyroid Gland Carcinoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7.
Sponsors: ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology.
Trust Score: 86/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Smilow Cancer Center/Yale-New Haven Hospital has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Smilow Cancer Center/Yale-New Haven Hospital has 126 clinical trials on record, with 90 currently active. Their work covers Refractory Differentiated Thyroid Gland Carcinoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7.
Yes — Smilow Cancer Center/Yale-New Haven Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.